Congenital keratosis abnormality
Conditions
Interventions
Apply the barrier improving agent to one side(forearm or lower thigh) and placebo to the other side(forearm or lower thigh) twice a day for 1 week
Sponsors
Asahikawa Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Congenital keratosis abnormality
Exclusion criteria
Exclusion criteria: 1.Those who have allergy to the ingredients to be tested 2.For pregnant and lactating women 3.Those who judge that they are inappropriate by the doctor in charge of conducting the study and the supervisor physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement degree of the appearance score using Observer dryness scale before the start of the study and 1 week after application of the barrier improvement agent | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement degree of VAS value of itch | — |
Countries
Japan
Contacts
Public ContactAkemi Yamamoto
Asahikawa Medical University Dermatological Department
Outcome results
None listed